Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology

Publication Venue For
- Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.. 25:547-554. 2016
- Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.. 24:913-920. 2015
- Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.. 23:2936-2942. 2014
- Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database.. 23:2349-2356. 2014
- Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial.. 23:1944-1947. 2014
- Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases.. 23:274-281. 2014
- Single-nucleotide polymorphisms in nucleotide excision repair genes, cigarette smoking, and the risk of head and neck cancer.. 22:1428-1445. 2013
- Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE Study.. 21:576-581. 2012
- Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer.. 20:2438-2449. 2011
- Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers.. 20:1912-1917. 2011
- A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.. 20:1078-1088. 2011
- Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.. 18:3133-3137. 2009
- Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.. 18:1953-1961. 2009
- Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans.. 18:1552-1561. 2009
- Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium.. 18:1544-1551. 2009
- Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study.. 18:1379-1385. 2009
- Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.. 18:1232-1238. 2009
- Human biospecimen research: experimental protocol and quality control tools.. 18:1017-1025. 2009
- Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.. 18:935-944. 2009
- Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.. 18:541-550. 2009
- Race/ethnicity, physical activity, and quality of life in breast cancer survivors.. 18:656-663. 2009
- Association and interactions between DNA repair gene polymorphisms and adult glioma.. 18:204-214. 2009
- Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.. 18:28-34. 2009
- Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study.. 18:314-320. 2009
- Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer.. 17:3467-3473. 2008
- Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.. 17:3577-3587. 2008
- Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.. 17:3567-3572. 2008
- Comparing the reliability of responses to telephone-administered versus self-administered Web-based surveys in a case-control study of adult malignant brain cancer.. 17:2639-2646. 2008
- Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique.. 17:2350-2355. 2008
- ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention.. 17:1884-1890. 2008
- Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.. 17:1974-1981. 2008
- Cyclin E overexpression relates to ovarian cancer histology but not to risk factors.. 17:1841. 2008
- Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis.. 17:1822-1831. 2008
- Performance of amplified DNA in an Illumina GoldenGate BeadArray assay.. 17:1781-1789. 2008
- The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.. 17:1739-1745. 2008
- DNA repair capacity and lung cancer risk in never smokers.. 17:1322-1328. 2008
- Informed consent for biorepositories: assessing prospective participants' understanding and opinions.. 17:1440-1451. 2008
- Differences in baseline characteristics and outcomes at 1- and 2-year follow-up of cancer survivors accrued via self-referral versus cancer registry in the FRESH START Diet and exercise trial.. 17:1288-1294. 2008
- Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.. 17:768-776. 2008
- Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.. 17:585-593. 2008
- Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium.. 17:484-489. 2008
- Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.. 17:397-404. 2008
- Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.. 16:2587-2593. 2007
- Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk.. 16:2756-2762. 2007
- Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.. 16:2379-2386. 2007
- GLIOGENE an International Consortium to Understand Familial Glioma.. 16:1730-1734. 2007
- Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.. 16:1822-1827. 2007
- Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.. 16:1633-1638. 2007
- Common variation in the BRCA1 gene and prostate cancer risk.. 16:1510-1516. 2007
- Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study.. 16:1356-1363. 2007
- Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.. 16:1294-1297. 2007
- Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.. 16:1032-1034. 2007
- Dietary mutagen exposure and risk of pancreatic cancer.. 16:655-661. 2007
- Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology.. 16:613-616. 2007
- Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.. 16:473-480. 2007
- In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry.. 16:223-227. 2007
- Pooling of case specimens to create standard serum sets for screening cancer biomarkers.. 16:334-341. 2007
- Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.. 16:50-56. 2007
- Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites.. 15:2364-2369. 2006
- Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.. 15:2526-2532. 2006
- Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.. 15:2311-2313. 2006
- Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers.. 15:1703-1707. 2006
- Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.. 15:1336-1340. 2006
- Barriers to full colon evaluation for a positive fecal occult blood test.. 15:1232-1235. 2006
- DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.. 15:886-891. 2006
- Mathematical modeling: epidemiology meets systems biology.. 15:827-829. 2006
- Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.. 15:935-938. 2006
- APC I1307K and the risk of prostate cancer.. 15:468-473. 2006
- Combined effects of the p53 and p73 polymorphisms on lung cancer risk.. 15:158-161. 2006
- No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.. 15:175-177. 2006
- Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.. 14:3013-3014. 2005
- Interest in testing for genetic susceptibility to lung cancer among Black college students "at risk" of becoming cigarette smokers.. 14:2978-2981. 2005
- Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.. 14:2536-2543. 2005
- Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.. 14:2413-2418. 2005
- Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck.. 14:1961-1966. 2005
- Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.. 14:2035-2039. 2005
- The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.. 14:1883-1889. 2005
- XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.. 14:1810-1818. 2005
- 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.. 14:1470-1476. 2005
- Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.. 14:1557-1561. 2005
- Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer.. 14:1453-1459. 2005
- Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms.. 14:1477-1484. 2005
- Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis.. 14:1188-1193. 2005
- Response rates to a mailed survey targeting childhood cancer survivors: a comparison of conditional versus unconditional incentives.. 14:1330-1332. 2005
- CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck.. 14:1034-1036. 2005
- Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.. 14:821-825. 2005
- Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration.. 14:790-798. 2005
- Safety and efficacy of weekly oral oltipraz in chronic smokers.. 14:892-899. 2005
- The biology of tobacco and nicotine: bench to bedside.. 14:764-767. 2005
- IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.. 14:403-408. 2005
- Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.. 13:2141-2147. 2004
- Racial differences in enrolment in a cancer genetics registry.. 13:1349-1354. 2004
- No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck.. 13:1081-1083. 2004
- Modifying attributions of colorectal cancer risk.. 13:560-566. 2004
- High-throughput detection of glutathione s-transferase polymorphic alleles in a pediatric cancer population.. 13:304-313. 2004
- Association between low dietary folate intake and suboptimal cellular DNA repair capacity.. 12:963-969. 2003
- Dietary folate intake and lung cancer risk in former smokers: a case-control analysis.. 12:980-986. 2003
- Genetic susceptibility to lung cancer: the role of DNA damage and repair.. 12:689-698. 2003
- No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.. 12:226-227. 2003
- Correspondence re: Zheng et al, Haplotype of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. 11: 640-645, 2002.. 12:71. 2003
- DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.. 11:1142-1143. 2002
- Environmental factors in relation to breast cancer characterized by p53 protein expression.. 11:829-835. 2002
- Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.. 11:640-645. 2002
- The impact of item order on ratings of cancer risk perception.. 11:654-659. 2002
- Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income.. 11:521-528. 2002
- Communicating breast cancer risks to women using different formats.. 10:895-898. 2001
- Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000.. 10:415-416. 2001
- PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.. 10:411-412. 2001
- Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.. 10:397-401. 2001
- Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx.. 10:273-275. 2001
- No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study.. 9:1267-1268. 2000
- Relationships among breast cancer perceived absolute risk, comparative risk, and worries.. 9:973-975. 2000
- The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.. 9:439-442. 2000
- Early onset baldness and prostate cancer risk.. 9:325-328. 2000
- Increased weight & body fatness associated with chemotherapy for breast cancer ... & what can be done?. 9:236-236. 2000
- Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction.. 8:801-807. 1999
- Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer.. 8:533-539. 1999
- Environmental contaminants and body fat distribution.. 8:179-183. 1999
- Debrisoquine hydroxylase (CYP2D6) and prostate cancer.. 7:1075-1078. 1998
- Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.. 7:483-488. 1998
- Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.. 7:553-555. 1998
- Reduced DNA repair capacity in head and neck cancer patients.. 7:465-468. 1998
- Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.. 7:371-378. 1998
- Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer.. 7:309-314. 1998
- A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.. 6:189-192. 1997
- Relationships among objective and subjective risk for breast cancer and mammography stages of change.. 5:1005-1011. 1996
- Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia.. 5:639-644. 1996
- The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.. 5:329-335. 1996
- Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.. 4:715-720. 1995
- Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.. 3:597-605. 1994
- Vitamin D and prostate cancer: a prediagnostic study with stored sera.. 2:467-472. 1993
- Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.. 2:329-333. 1993
- Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients.. 2:103-106. 1993
- Identification of women at increased risk for breast cancer in a population-based screening program.. 1:143-147. 1992
- Attitudes, perceptions, and strategies toward increasing cancer screening, treatment, and participation in research among Latinos. 2018
- Determinants of delays in care-seeking for ovarian cancer symptoms in African American women. 2018
- Developing effective community and health system partnerships to advance health equity and health disparities research. 2018
- Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer. 2018
- Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models 2018
- Establishment of African American prostate cancer patient-derived primary cell lines and xenografts. 2018
- Nutritional profiling reveals glutamine-utilizing transaminases as a metabolic vulnerability of TAZ/YAP-driven breast cancer cells 2018
- Race-related differential splicing of the insulin receptor: A novel target underlying prostate cancer disparities 2018
- Acculturation and Ethnic Variations in Breast Cancer Risk Factors, Gail Model Risk Estimates and Mammographic Breast Density 2015
- Predictors of Colorectal Cancer Surveillance among Radiation-treated Survivors of Childhood Cancer 2013
- Oncogenic pathway signatures in human cancers as a guide to targeted therapies. 2005
- Results from project LEAD (Leading the way in Exercise And Diet): A lifestyle intervention trial aimed at older adults diagnosed with breast and prostate cancer. 2005
- Supplemental vitamin E increases biomarkers of estrogen stimulation in random core breast biopsies of women taking tamoxifen 2005
- Childhood cancer survivors: Health behaviors and receptivity to health promotion interventions. 2004
- Screening for therapy-related second cancers. 2004
- Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. 2004
- Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer. 2003
- Imsulin-like growth factor-1 (IGF-1): An exploration of serum levels, binding protein (IGFBP-3) and IGF-1 CA repeat genotype, and the risk of prostae cancer 2003
- A case-control study of candidate ovarian cancer susceptibility polymorphisms. 2002
- Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia. 2002
- Evaluation of ovarian cancer preventive agents in the chicken. 2002
- Randomized controlled clinical trial of weekly oltipraz in smokers. 2002

Publication Venue For